← All companies

IMTX

Immatics N.V.

IMTX Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$9.02

+0.36 +4.16%

Key statistics

from XBRL data in SEC filings

Market cap

$1.21B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$5.05 – $12.41

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jun 18, 2026 6-K FORM 6-K Jun 2, 2026 6-K FORM 6-K Jun 1, 2026 6-K May 12, 2026 6-K FORM 6-K Apr 21, 2026 6-K FORM 6-K Apr 17, 2026 20-F Mar 5, 2026 6-K FORM 6-K Mar 5, 2026 6-K FORM 6-K Jan 12, 2026 6-K FORM 6-K Dec 11, 2025 6-K FORM 6-K Dec 8, 2025 6-K Nov 17, 2025 6-K FORM 6-K Nov 12, 2025 6-K FORM 6-K Oct 27, 2025 6-K FORM 6-K Oct 20, 2025 6-K FORM 6-K Oct 1, 2025 6-K Aug 13, 2025 6-K FORM 6-K Jun 18, 2025 6-K FORM 6-K Jun 2, 2025 6-K FORM 6-K Jun 2, 2025 6-K May 13, 2025 6-K FORM 6-K Mar 27, 2025 20-F Mar 27, 2025 6-K FORM 6-K Jan 13, 2025 6-K FORM 6-K Dec 13, 2024 6-K Nov 18, 2024 6-K FORM 6-K Nov 8, 2024 6-K FORM 6-K Oct 15, 2024 6-K FORM 6-K Oct 10, 2024 6-K FORM 6-K Sep 16, 2024 6-K Aug 13, 2024 6-K FORM 6-K Jul 31, 2024 6-K FORM 6-K Jun 20, 2024 6-K FORM 6-K Jun 3, 2024 6-K May 14, 2024 6-K FORM 6-K Mar 21, 2024 20-F Mar 21, 2024 6-K FORM 6-K Jan 22, 2024 6-K Nov 14, 2023 6-K FORM 6-K Nov 8, 2023